Bioelectronics Corp (BIEL) 0.0027 $BIEL
BioElectronics' OTC ActiPatch® Musculoskeletal Pain Therapy Clinically Proven to Reduce Osteoarthritis Pain and Disability
PR Newswire - Wed May 14, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today announced more detail on the interim results of a randomized, double blind, placebo controlled trial on osteoarthritis of the knee (knee pain) using ActiPatch® Therapy. The interim results are now published online at the EULAR (European League against Arthritis) conference website at https://b-com.mci-group.com/AbstractList/EULAR2014.aspx and search for abstract #: AB0777.
BioElectronics Corp. A Sub-Penny Opportunity in Health Care Industry Analyst Report
PR Newswire - Mon May 12, 6:30AM CDT
BioElectronics Corp. (OTCBB: BIEL) One-third of the world's population suffers from chronic pain and many go untreated due to the lack of efficacious therapy, the cost, and the dangerous side effects of drug therapy. Chronic pain is pervasive throughout the world. Pain affects more than 100 million Americans, which is more than diabetes, heart disease and cancer, combined.
Osteoarthritis Study shows ActiPatch® Therapy Significantly Relieves Knee Pain
PR Newswire - Wed Apr 16, 8:00AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced reports on preliminary results of a randomized, double blind, placebo controlled trial on osteoarthritis of the knee (knee pain) using ActiPatch® Therapy.
Clear Channel Business Talk Radio's 'The Traders Network' Interview With Andrew J. Whelan, CEO of BioElectronics Corp Now Available for Online Streaming
Marketwire - Tue Apr 15, 8:56AM CDT
The Traders Network Show Broadcasted live Daily on Clear Channel Business Talk Radio announced today that Andrew Whelan CEO of BioElectronics Corporation (PINKSHEETS: BIEL) the maker of advanced consumer medical devices full interview archive and recap in now Available. Hosted Michael Yorba, the two-segment exclusive dives into the business of pain relief, BIEL's opiate alternatives and what the future holds for BioElectronics Corp in 2014
BioElectronics Device Alleviates Dental Surgical Trauma
PR Newswire - Tue Mar 25, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that Dr. Bartolomeo Operti MD, Chief of Anesthesia Department Day Hospital Section of Maria Adelaide Hospital and Dr. Tiziano Tealdo, Clinical Instructor at University of Genova, Valle Belbo Implant Center have completed a white paper detailing their results regarding the use of BioElectronics medical device, RecoveryRx® Therapy.
BioElectronics CEO Andrew Whelan to Be Interviewed Live Wednesday on Clear Channel Business Talk Radio
Marketwire - Mon Mar 24, 7:20AM CDT
BioElectronics Corporation (PINKSHEETS: BIEL), the maker of advanced consumer medical devices, today announced that CEO Andrew Whelan will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
Depository Trust Company (DTC) Lifts Chill on BioElectronics Shares
PR Newswire - Thu Mar 20, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that the Depository Trust Company has determined to end the deposit transaction restriction (the Deposit Chill) it had previously placed on shares of BioElectronics.
BioElectronics' ActiPatch® and Allay® are Now Available in Austria
PR Newswire - Tue Mar 18, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that Biomax, Inc. and One Globe Biotechnology LLC will exclusively distribute ActiPatch® and Allay® Therapy to Austria's population of over eight million.
BioElectronics Developer of Unique Consumer Medical Devices Appoints Deepak Kotak, MD, Esq as Executive Vice President
eTeligis - Tue Mar 11, 11:32AM CDT
BioElectronics Corporation (OTC Pink: BIEL)(PINKSHEETS: BIEL), the maker of advanced consumer medical devices, has appointed Dr. Deepak Kotak MA (Oxford), MBBS, FRCA, MRCP, LLDip, LLM as Executive Vice President.
BioElectronics Appoints Deepak Kotak, MD, Esq as Executive Vice President
PR Newswire - Tue Mar 11, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices has appointed Dr. Deepak Kotak MA (Oxford), MBBS, FRCA, MRCP, LLDip, LLM as Executive Vice President.
BioElectronics Wins High Commendation In "Most Innovative New OTC Product Award" From OTC Bulletin
PR Newswire - Fri Mar 07, 8:49AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices won citations in two award categories from the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products. The Smart Insole(TM) Heel Pain Therapy product was highly commended as the "Most Innovative New OTC Product Award" and the ActiPatch® Musculoskeletal Therapy was runner-up for its "Best New OTC Packaging Design Award."
New Education Campaign Seeks to Teach Consumers, Medical Pros to Fight Pain Without Drugs
PR Newswire - Tue Mar 04, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices and drug-free pain therapies, announced today that it is participating in upcoming consumer educational events and programs as part of an international campaign to discuss alternative pain modalities.
BioElectronics Corp.'s Stock Value Increases 32% on News of Animal Medical Devices
ACCESSWIRE - Tue Mar 04, 7:04AM CST
BioElectronics Corp. (OTCPink: BIEL) stock volume and share value soared Mar. 3, with 244,375,834 shares changing hands, more than 2.5 times its three-month average volume of 95,913,917 shares, while the value of its shares increased 32%.
BioElectronics Researchers And Clinicians Support FDA's Position To Reclassify Shortwave Medical Devices To Class II
PR Newswire - Thu Feb 27, 8:32AM CST
Medical device researchers and clinicians are optimistically supportive of the Food and Drug Administration's decision last week to reclassify and rename electronic shortwave diathermy for many other uses, a decision that may improve access to safe, clinically tested medical devices that serve as alternatives to risky pain medications.
Google Plus to feature Dr. Christine Dumas on Wednesday, February 26th
PR Newswire - Wed Feb 26, 9:36AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that Google Plus on Wednesday, February 26, at 2 PM EST (11 AM PST) will feature Dr. Christine Dumas reporting on alternative drug-free pain treatments.
BioElectronics Announces New Product
PR Newswire - Tue Feb 25, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, today announced that its fourth generation drug-free, anti-inflammatory medical devices will now be sold for use on pets and horses as the PetPatch® Loop $29.99.
BioElectronics Applauds FDA Recommendation to Reclassify Shortwave Medical Devices to Class II
PR Newswire - Fri Feb 21, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of disposable drug-free healing pain therapy devices welcomed the FDA recommendations announced today in their Docket No. FDA-2012-N-0378, "Physical Medicine Devices; Reclassification and Renaming of Shortwave Diathermy for All Other Uses."
Frost & Sullivan Commends XLink for Enabling Retailers to Seamlessly Switch between Network Connections
PR Newswire - Wed Feb 19, 2:00AM CST
Based on its recent research on the machine-to-machine (M2M) in retail and finance market, Frost & Sullivan presents XLink Communications with the 2014 South African Frost & Sullivan Award for Technology Leadership for its VersaLink platform. This is just one solution in a line of 3G routers offered by XLink for primary or backup communications in the point of sale (POS) electronic funds transfer (EFT) space.
BioElectronics' Innovative Pain Relief Products Nominated for Most Innovative New OTC Product Award and Others by OTC Bulletin
PR Newswire - Tue Feb 18, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that its ActiPatch® Musculoskeletal Pain Relief Therapy and Smart Insole(TM) Heel Pain Therapy products have received award nominations from the OTC Bulletin, the leading international trade publication for OTC developments worldwide.
Disinfectants - Global Strategic Business Report
PR Newswire - Fri Feb 14, 10:00AM CST
Dublin - Research and Markets (http://www.researchandmarkets.com/research/g94bqv/disinfectants) has announced the addition of the "Disinfectants - Global Strategic Business Report" report to their offering.
BioElectronics' OTC ActiPatch® Musculoskeletal Pain Therapy Clinically Proven to Reduce Osteoarthritis Pain and Disability
PR Newswire - Wed May 14, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today announced more detail on the interim results of a randomized, double blind, placebo controlled trial on osteoarthritis of the knee (knee pain) using ActiPatch® Therapy. The interim results are now published online at the EULAR (European League against Arthritis) conference website at https://b-com.mci-group.com/AbstractList/EULAR2014.aspx and search for abstract #: AB0777.
BioElectronics Corp. A Sub-Penny Opportunity in Health Care Industry Analyst Report
PR Newswire - Mon May 12, 6:30AM CDT
BioElectronics Corp. (OTCBB: BIEL) One-third of the world's population suffers from chronic pain and many go untreated due to the lack of efficacious therapy, the cost, and the dangerous side effects of drug therapy. Chronic pain is pervasive throughout the world. Pain affects more than 100 million Americans, which is more than diabetes, heart disease and cancer, combined.
Osteoarthritis Study shows ActiPatch® Therapy Significantly Relieves Knee Pain
PR Newswire - Wed Apr 16, 8:00AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced reports on preliminary results of a randomized, double blind, placebo controlled trial on osteoarthritis of the knee (knee pain) using ActiPatch® Therapy.
Clear Channel Business Talk Radio's 'The Traders Network' Interview With Andrew J. Whelan, CEO of BioElectronics Corp Now Available for Online Streaming
Marketwire - Tue Apr 15, 8:56AM CDT
The Traders Network Show Broadcasted live Daily on Clear Channel Business Talk Radio announced today that Andrew Whelan CEO of BioElectronics Corporation (PINKSHEETS: BIEL) the maker of advanced consumer medical devices full interview archive and recap in now Available. Hosted Michael Yorba, the two-segment exclusive dives into the business of pain relief, BIEL's opiate alternatives and what the future holds for BioElectronics Corp in 2014
BioElectronics Device Alleviates Dental Surgical Trauma
PR Newswire - Tue Mar 25, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that Dr. Bartolomeo Operti MD, Chief of Anesthesia Department Day Hospital Section of Maria Adelaide Hospital and Dr. Tiziano Tealdo, Clinical Instructor at University of Genova, Valle Belbo Implant Center have completed a white paper detailing their results regarding the use of BioElectronics medical device, RecoveryRx® Therapy.
BioElectronics CEO Andrew Whelan to Be Interviewed Live Wednesday on Clear Channel Business Talk Radio
Marketwire - Mon Mar 24, 7:20AM CDT
BioElectronics Corporation (PINKSHEETS: BIEL), the maker of advanced consumer medical devices, today announced that CEO Andrew Whelan will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
Depository Trust Company (DTC) Lifts Chill on BioElectronics Shares
PR Newswire - Thu Mar 20, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that the Depository Trust Company has determined to end the deposit transaction restriction (the Deposit Chill) it had previously placed on shares of BioElectronics.
BioElectronics' ActiPatch® and Allay® are Now Available in Austria
PR Newswire - Tue Mar 18, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that Biomax, Inc. and One Globe Biotechnology LLC will exclusively distribute ActiPatch® and Allay® Therapy to Austria's population of over eight million.
BioElectronics Developer of Unique Consumer Medical Devices Appoints Deepak Kotak, MD, Esq as Executive Vice President
eTeligis - Tue Mar 11, 11:32AM CDT
BioElectronics Corporation (OTC Pink: BIEL)(PINKSHEETS: BIEL), the maker of advanced consumer medical devices, has appointed Dr. Deepak Kotak MA (Oxford), MBBS, FRCA, MRCP, LLDip, LLM as Executive Vice President.
BioElectronics Appoints Deepak Kotak, MD, Esq as Executive Vice President
PR Newswire - Tue Mar 11, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices has appointed Dr. Deepak Kotak MA (Oxford), MBBS, FRCA, MRCP, LLDip, LLM as Executive Vice President.
BioElectronics Wins High Commendation In "Most Innovative New OTC Product Award" From OTC Bulletin
PR Newswire - Fri Mar 07, 8:49AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices won citations in two award categories from the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products. The Smart Insole(TM) Heel Pain Therapy product was highly commended as the "Most Innovative New OTC Product Award" and the ActiPatch® Musculoskeletal Therapy was runner-up for its "Best New OTC Packaging Design Award."
New Education Campaign Seeks to Teach Consumers, Medical Pros to Fight Pain Without Drugs
PR Newswire - Tue Mar 04, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices and drug-free pain therapies, announced today that it is participating in upcoming consumer educational events and programs as part of an international campaign to discuss alternative pain modalities.
BioElectronics Corp.'s Stock Value Increases 32% on News of Animal Medical Devices
ACCESSWIRE - Tue Mar 04, 7:04AM CST
BioElectronics Corp. (OTCPink: BIEL) stock volume and share value soared Mar. 3, with 244,375,834 shares changing hands, more than 2.5 times its three-month average volume of 95,913,917 shares, while the value of its shares increased 32%.
BioElectronics Researchers And Clinicians Support FDA's Position To Reclassify Shortwave Medical Devices To Class II
PR Newswire - Thu Feb 27, 8:32AM CST
Medical device researchers and clinicians are optimistically supportive of the Food and Drug Administration's decision last week to reclassify and rename electronic shortwave diathermy for many other uses, a decision that may improve access to safe, clinically tested medical devices that serve as alternatives to risky pain medications.
Google Plus to feature Dr. Christine Dumas on Wednesday, February 26th
PR Newswire - Wed Feb 26, 9:36AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that Google Plus on Wednesday, February 26, at 2 PM EST (11 AM PST) will feature Dr. Christine Dumas reporting on alternative drug-free pain treatments.
BioElectronics Announces New Product
PR Newswire - Tue Feb 25, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, today announced that its fourth generation drug-free, anti-inflammatory medical devices will now be sold for use on pets and horses as the PetPatch® Loop $29.99.
BioElectronics Applauds FDA Recommendation to Reclassify Shortwave Medical Devices to Class II
PR Newswire - Fri Feb 21, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of disposable drug-free healing pain therapy devices welcomed the FDA recommendations announced today in their Docket No. FDA-2012-N-0378, "Physical Medicine Devices; Reclassification and Renaming of Shortwave Diathermy for All Other Uses."
Frost & Sullivan Commends XLink for Enabling Retailers to Seamlessly Switch between Network Connections
PR Newswire - Wed Feb 19, 2:00AM CST
Based on its recent research on the machine-to-machine (M2M) in retail and finance market, Frost & Sullivan presents XLink Communications with the 2014 South African Frost & Sullivan Award for Technology Leadership for its VersaLink platform. This is just one solution in a line of 3G routers offered by XLink for primary or backup communications in the point of sale (POS) electronic funds transfer (EFT) space.
BioElectronics' Innovative Pain Relief Products Nominated for Most Innovative New OTC Product Award and Others by OTC Bulletin
PR Newswire - Tue Feb 18, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that its ActiPatch® Musculoskeletal Pain Relief Therapy and Smart Insole(TM) Heel Pain Therapy products have received award nominations from the OTC Bulletin, the leading international trade publication for OTC developments worldwide.
Disinfectants - Global Strategic Business Report
PR Newswire - Fri Feb 14, 10:00AM CST
Dublin - Research and Markets (http://www.researchandmarkets.com/research/g94bqv/disinfectants) has announced the addition of the "Disinfectants - Global Strategic Business Report" report to their offering.
